Archived results and presentations

Late-stage pipeline investor science webcast presentation

PDF 4,629KB

Year-to-date and Q3 2016 Results announcement

PDF 1,506KB

Year-to-date and Q3 2016 Clinical trials appendix

PDF 2,405KB

Year-to-date and Q3 2016 Results presentation

PDF 4,519KB

Year-to-date and Q3 2016 Results transcript

PDF 170KB

ERS Investor science webcast presentation

PDF 1,912KB

ERS Investor science webcast transcript

PDF 195KB

DNA Damage Response analyst science event

PDF 2,953KB

H1 2016 Results announcement

PDF 12,302KB

H1 2016 Presentation

PDF 1,441KB

H1 2016 Clinical trials appendix

PDF 2,188KB

H1 2016 Results transcript

PDF 227KB

AstraZeneca Investor Science Event at ASCO 2016

PDF 2,847KB

Q1 2016 results press release

PDF 2,093KB

Clinical trials appendix Q1 2016 update

PDF 2,473KB

Q1 2016 results presentation

PDF 578KB

Q1 2016 results transcript

PDF 378KB

Full-Year and Q4 2015 Results presentation

PDF 1,111KB

Fourth quarter and Full-Year Results 2015 press release

PDF 13,306KB

Clinical Trials Appendix Q4 2015

PDF 2,500KB

Full-Year and Q4 2015 Results transcript

PDF 238KB

J.P. Morgan Healthcare Conference 2016 presentation

PDF 1,731KB

Acerta Investor conference call presentation

PDF 1,615KB

Acerta Investor conference call transcript

PDF 140KB

Late-stage pipeline call presentation

PDF 8,034KB

ACR Investor science conference call transcript

PDF 206KB

ACR Investor science conference call presentation

PDF 3,280KB

ZS Pharma Investor conference call presentation

PDF 782KB

Q3 2015 results presentation

PDF 1,987KB

Press release & pipeline update Q3 2015

PDF 1,973KB

Clinical Trials Appendix Q3 2015 Update

PDF 2,349KB

H1 results 2015 presentation

PDF 1,030KB

H1 results 2015 press release & pipeline update

PDF 2,049KB

H1 results 2015 clinical trials appendix

PDF 2,198KB

ASCO 2015 Investor science event presentation

PDF 3,554KB

ASCO 2015 Investor science event biographies

AstraZeneca Mölndal presentation

PDF 13,683KB

Q1 results 2015 presentation

PDF 1,015KB

Q1 results 2015 press release & pipeline update

PDF 439KB

Q1 results 2015 clinical trials appendix

PDF 2,979KB

ACC 2015 Investor science conference call presentation

PDF 6,807KB

Q4 and full year results 2014 presentation

PDF 1,912KB

Q4 and full year results 2014 press release & development pipeline

PDF 535KB

Q4 and full year results 2014 clinical trials appendix

PDF 658KB

J.P. Morgan Healthcare Conference presentation

PDF 348KB

Introduction – Pascal Soriot

PDF 527KB

Core therapeutic areas presentation – Luke Miels

PDF 1,068KB

Emerging markets/Japan presentation – Mark Mallon

PDF 530KB

Pipeline: Respiratory, inflammation & autoimmunity presentation – Bing Yao

PDF 583KB

Pipeline: Cardiovascular & metabolic disease presentation – Elisabeth Björk

PDF 2,423KB

Pipeline: Oncology presentation – Susan Galbraith/Mohammed Dar

PDF 2,210KB

Late-stage development presentation – Briggs Morrison

PDF 407KB

Innovative medicines and early development presentation – Mene Pangalos

PDF 2,735KB

MedImmune presentation – Bahija Jallal

PDF 2,010KB

Finance presentations – Marc Dunoyer

PDF 380KB

Closing remarks – Pascal Soriot

PDF 314KB

Presenter biographies

PDF 1,369KB

Appendix – Epidemiology

PDF 245KB

Q3 and nine months results 2014 presentation

PDF 1,443KB

Q3 and nine months results 2014 press release

PDF 414KB

Q3 and nine months results 2014 pipeline table

PDF 118KB

Q3 and nine months results 2014 clinical trial programmes summary

PDF 1,967KB

ESMO 2014 presentation

PDF 1,125KB

ESMO 2014 analyst call transcript

PDF 58KB

ESMO 2014 webcast

WEBCAST 81,790KB

Q2 and half year results 2014 presentation

PDF 1,371KB

Q2 and half year results 2014 press release

PDF 267KB

Q2 and half year results 2014 clinical trial programmes summary

WEBCAST 789KB

Q2 and half year results 2014 transcript

WEBCAST 55KB

Strategic Transaction with Almirall in Respiratory Disease presentation

PDF 879KB

American Society of Clinical Oncology (ASCO) 2014

PDF 2,893KB

ATS 2014 presentation

PDF 10,592KB

ATS 2014 transcript

PDF 100KB

ATS 2014 webcast

WEBCAST 63,941KB

Analyst update presentation

PDF 962KB

Q1 results 2014 presentation

PDF 1,371KB

Q1 results 2014 press release

PDF 292KB

Q1 results 2014 development pipeline table

PDF 101KB

Q1 results 2014 webcast

WEBCAST 75,282KB

Q4 and full year results 2013 press release

PDF 2,074KB

Q4 and full year results 2013 development pipeline table

PDF 602KB

Q4 and full year results 2013 presentation

PDF 2,412KB

Q4 and full year results 2013 clinical programmes summary

PDF 1,314KB

Q4 and full year results 2013 transcript

PDF 218KB

J.P. Morgan Healthcare Conference presentation

PDF 1,690KB

J.P. Morgan Healthcare Conference development pipeline table

PDF 602KB

Diabetes alliance presentation

PDF 746KB

Diabetes alliance transaction overview

PDF 112KB

MedImmune R&D Roadshow presentation

PDF 3,440KB

Q3 and nine months results 2013 presentation

PDF 598KB

Q3 and nine months results 2013 press release

PDF 343KB

Q2 and half year results 2013 presentation

PDF 1,487KB

Q2 and half year results 2013 press release

PDF 224KB

Q2 results 2013 pipeline table

PDF 548KB

Q2 and half year results 2013 – Pascal Soriot (CEO) script

PDF 250KB

Q2 and half year results 2013 – Simon Lowth (CFO) script

PDF 261KB

ASCO briefing presentation

PDF 558KB

Q1 results 2013 press release

PDF 1,306KB

Q1 results 2013 presentation

PDF 424KB

Q1 results 2013 Simon Lowth (CFO) script

PDF 267KB

Investor Day 2013 presentation

PDF 2,584KB

Investor Day 2013 agenda

PDF 65KB

Investor Day 2013 cautionary statement

PDF 59KB

Q4 and full year results 2012 press release

PDF 353KB

Q4 and full year results 2012 development pipeline table

PDF 383KB

Q4 and full year results 2012 presentation

PDF 59KB

Q4 and full year results 2012 – Pascal Soriot opening script

PDF 107KB

Q4 and full year results 2012 – Briggs Morrison script

PDF 149KB

Q4 and full year results 2012 – Simon Lowth script

PDF 109KB

Q4 and full year results 2012 – Pascal Soriot closing script

PDF 58KB

J.P. Morgan Healthcare Conference presentation

PDF 1,684KB

Fostamatinib analyst briefing presentation

PDF 1,382KB

Q3 and nine months results 2012 presentation

PDF 356KB

Q3 and nine months results 2012 analyst call script

PDF 107KB

Naloxegol educational presentation

PDF 832KB

Q2 and half year results 2012 presentation

PDF 316KB

Q2 and half year results 2012 – Simon Lowth (Interim CEO) script

PDF 213KB

Q2 and half year results 2012 – Tony Zook (Executive Vice-President Commercial Operations) script

PDF 234KB

Q2 and half year results 2012 – Julie Brown (Interim CFO) script

PDF 226KB

AstraZeneca business update presentation

PDF 256KB

AstraZeneca business update – Simon Lowth (Interim CEO) script

PDF 245KB

R&D Roundtable presentation

PDF 2,416KB

Q1 results 2012 presentation

PDF 346KB

Q1 results 2012 – David Brennan (CEO) script

PDF 76KB

Q1 results 2012 – Simon Lowth (CFO) script

PDF 115KB

Q4 and full year results 2011 presentation

PDF 1,595KB

Q4 and full year results 2011 – David Brennan (CEO) script

PDF 65KB

Q4 and full year results 2011 Simon Lowth (CFO) script

PDF 90KB

Q4 and full year results 2011 – Martin Mackay (President R&D) script

PDF 108KB

Q4 and full year results 2011 – Tony Zook (EVP Commercial Operations) script

PDF 66KB

30th Annual J.P. Morgan Healthcare Conference presentation

PDF 1,335KB